Early Haemodynamic Performance and Clinical Outcomes of a Novel Bioprosthetic Mitral Valve
MITRIS RESILIA demonstrated stable early haemodynamic performance across all valve sizes, including the 23 mm prosthesis. No cases of structural valve deterioration or paravalvular leak were observed, supporting its feasibility for mitral valve replacement. Further studies with extended follow-up are required to confirm the long-term durability and clinical benefits of the valve.
Authors
- Yuki Wada (ORCID: https://orcid.org/0000-0003-4314-2001)
- Akira Marui (ORCID: https://orcid.org/0000-0003-2792-4863)
- Keisuke Hakamada
- Yuta Kitagata (ORCID: https://orcid.org/0000-0001-5386-8194)
- Kazuya Terazono
- Atsushi Nagasawa
- Shinichi Tsumaru (ORCID: https://orcid.org/0000-0001-6966-8541)
- Nobuhisa Ohno
- Hironori Mihara
Institutions
- Kokura Memorial Hospital (JP)
Publication Details
- Journal
- Interdisciplinary CardioVascular and Thoracic Surgery
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1093/icvts/ivaf186
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00